1. Home
  2. NCPL vs CPHI Comparison

NCPL vs CPHI Comparison

Compare NCPL & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCPL

Netcapital Inc.

HOLD

Current Price

$0.92

Market Cap

9.2M

Sector

Finance

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$1.69

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCPL
CPHI
Founded
1984
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NCPL
CPHI
Price
$0.92
$1.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
372.3K
11.7K
Earning Date
12-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$917,291.00
$4,052,266.00
Revenue This Year
$739.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.20
52 Week High
$8.75
$3.35

Technical Indicators

Market Signals
Indicator
NCPL
CPHI
Relative Strength Index (RSI) 32.89 53.42
Support Level $0.81 $1.45
Resistance Level $1.26 $1.88
Average True Range (ATR) 0.26 0.09
MACD -0.01 0.03
Stochastic Oscillator 22.22 58.14

Price Performance

Historical Comparison
NCPL
CPHI

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: